ClinicalTrials.Veeva

Menu

Thalassemia Screening by Third Generation Sequencing

C

Chiang Mai University

Status

Active, not recruiting

Conditions

Thalassemia Trait
Thalassemia; Mixed

Treatments

Procedure: blood draw

Study type

Interventional

Funder types

Other

Identifiers

NCT05552690
513/2021

Details and patient eligibility

About

Test globin gene in participants

Full description

Recruit individuals who documented as thalassemia carrier or disease and who positive thalassemia screening but unknown mutation.

Blood will be sent for third generation sequencing to review alpha and beta globin gene mutation.

Enrollment

20 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Thalassemia carriers or disease individuals with documented as known globin gene mutation.
  2. Thalassemia carriers or disease individuals whose mutation did not retrieve from conventional technique and were assigned as no known mutation

Exclusion criteria

-incomplete medical data

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Thalassemia screening positive
Other group
Description:
In this study only 1 group of participants. No comparative. Only description
Treatment:
Procedure: blood draw

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems